Customise results display
Results 1-5 of 5 (Search time: 0.167 seconds).
|2007-01-01||Healthcare Use and Costs of Medium-chain Acyl-Coa Dehydrogenase Deficiency in Australia: Screening Versus No Screening||Haas, M; Chaplin, M; Joy, P; Wiley, V; Black, C; Wilcken, B|
|2009-08-01||Expanded newborn screening: Outcome in screened and unscreened patients at age 6 years||Wilcken, B; Haas, M; Joy, P; Wiley, V; Bowling, F; Carpenter, K; Christodoulou, J; Cowley, D; Ellaway, C; Fletcher, J; Kirk, EP; Lewis, B; McGill, J; Peters, H; Pitt, J; Ranieri, E; Yaplito-Lee, J; Boneh, A|
|2007-01-06||Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study||Wilcken, B; Haas, M; Joy, P; Wiley, V; Chaplin, M; Black, C; Fletcher, J; McGill, J; Boneh, A|
|2009-02-01||Economic evaluation of tandem mass spectrometry newborn screening in Australia||Norman, R; Haas, M; Chaplin, M; Joy, P; Wilcken, B|
|2009-01-01||Neuropsychological functioning in children with medium chain acyl coenzyme A dehydrogenase deficiency (MCADD): The impact of early diagnosis and screening on outcome||Joy, P; Black, C; Rocca, A; Haas, M; Wilcken, B|